| First Author | Yokota A | Year | 2005 |
| Journal | Mol Immunol | Volume | 42 |
| Issue | 1 | Pages | 71-8 |
| PubMed ID | 15488945 | Mgi Jnum | J:93039 |
| Mgi Id | MGI:3055637 | Doi | 10.1016/j.molimm.2004.07.042 |
| Citation | Yokota A, et al. (2005) Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis. Mol Immunol 42(1):71-8 |
| abstractText | Using a panel of transfectant B lymphoma cells expressing varying amounts of the mutant Fas together with the endogenous wild type Fas, semi-quantitative studies on the dominant negative effect of a murine mutant Fas molecule lacking death domain were carried out. In anti-Fas antibody-mediated induction of apoptosis, the mutant molecules exerted significant dominant-negative effect only when their expression level was comparable to or higher than that of wild type molecules, or when exposed to low amounts of the antibody. The inhibitory effect was accompanied by the failure in DISC formation in spite of Fas aggregation. When they were subjected to T cell-mediated Fas-based induction of apoptosis, however, the dominant negative effect was prominent such that the expression of even a small amount of the mutant molecules resulted in significant inhibition. Such a strong inhibitory effect explains the dominant phenotype of this type of mutant Fas molecules in ALPS heterozygous patients and also implies that the physiological effectors for Fas in vivo are cells, i.e., FasL-expressing activated T cells. |
